ANTICARDIOLIPIN - ANVISA Registration 80254180344

Access comprehensive regulatory information for ANTICARDIOLIPIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180344 and manufactured by PHADIA AB. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, PHADIA AB, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80254180344
Registration Details
ANVISA Registration Number: 80254180344
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

EliA IgM Conjugate 200
Risk Class II

Registration Details

80254180344

25351628942201916

04930429000139

Company Information

PHADIA AB
Sweden
PT: SUÉCIA

Dates and Status

Jan 27, 2020

VIGENTE

09/18/2025 19:00:01